Review





Similar Products

gene exp wisp2 hs01031984 m1  (Thermo Fisher)
94
Thermo Fisher gene exp wisp2 hs01031984 m1
qPCR validation of differentially expressed genes. ( A ) GDF5 . ( B ) <t>CCN5</t> . ( C ) SKIL . For each gene, cumulative results ( n = 5 donors) are showed, together with donors clustered by response to miRNA inhibitor treatment: responders (#162, #217, #255) and non-responders (#152, #157). * p < 0.05
Gene Exp Wisp2 Hs01031984 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp wisp2 hs01031984 m1/product/Thermo Fisher
Average 94 stars, based on 1 article reviews
gene exp wisp2 hs01031984 m1 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
wisp2  (Aviva Systems)
94
Aviva Systems wisp2
qPCR validation of differentially expressed genes. ( A ) GDF5 . ( B ) <t>CCN5</t> . ( C ) SKIL . For each gene, cumulative results ( n = 5 donors) are showed, together with donors clustered by response to miRNA inhibitor treatment: responders (#162, #217, #255) and non-responders (#152, #157). * p < 0.05
Wisp2, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wisp2/product/Aviva Systems
Average 94 stars, based on 1 article reviews
wisp2 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
wisp2 sc-514070 antibody  (Santa Cruz Biotechnology)
90
Santa Cruz Biotechnology wisp2 sc-514070 antibody
qPCR validation of differentially expressed genes. ( A ) GDF5 . ( B ) <t>CCN5</t> . ( C ) SKIL . For each gene, cumulative results ( n = 5 donors) are showed, together with donors clustered by response to miRNA inhibitor treatment: responders (#162, #217, #255) and non-responders (#152, #157). * p < 0.05
Wisp2 Sc 514070 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wisp2 sc-514070 antibody/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
wisp2 sc-514070 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
wisp2  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology wisp2
qPCR validation of differentially expressed genes. ( A ) GDF5 . ( B ) <t>CCN5</t> . ( C ) SKIL . For each gene, cumulative results ( n = 5 donors) are showed, together with donors clustered by response to miRNA inhibitor treatment: responders (#162, #217, #255) and non-responders (#152, #157). * p < 0.05
Wisp2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wisp2/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
wisp2 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
gene exp wisp2 hs00180242 m1  (Thermo Fisher)
95
Thermo Fisher gene exp wisp2 hs00180242 m1
qPCR validation of differentially expressed genes. ( A ) GDF5 . ( B ) <t>CCN5</t> . ( C ) SKIL . For each gene, cumulative results ( n = 5 donors) are showed, together with donors clustered by response to miRNA inhibitor treatment: responders (#162, #217, #255) and non-responders (#152, #157). * p < 0.05
Gene Exp Wisp2 Hs00180242 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp wisp2 hs00180242 m1/product/Thermo Fisher
Average 95 stars, based on 1 article reviews
gene exp wisp2 hs00180242 m1 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
protein levels of efna1、tyms and wisp2  (Human Protein Atlas)
90
Human Protein Atlas protein levels of efna1、tyms and wisp2
The expression level and diagnostic efficacy of candidate markers (EFNA1, TYMS and <t>WISP2)</t> in CC and OC. A , C The expression level of 3 candidate biomarkers between tumor and normal groups. B , D The ROC curves of the 3 candidate biomarkers in CC and OC
Protein Levels Of Efna1、Tyms And Wisp2, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protein levels of efna1、tyms and wisp2/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
protein levels of efna1、tyms and wisp2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
wisp2 gene  (Almac Inc)
90
Almac Inc wisp2 gene
The expression level and diagnostic efficacy of candidate markers (EFNA1, TYMS and <t>WISP2)</t> in CC and OC. A , C The expression level of 3 candidate biomarkers between tumor and normal groups. B , D The ROC curves of the 3 candidate biomarkers in CC and OC
Wisp2 Gene, supplied by Almac Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wisp2 gene/product/Almac Inc
Average 90 stars, based on 1 article reviews
wisp2 gene - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


qPCR validation of differentially expressed genes. ( A ) GDF5 . ( B ) CCN5 . ( C ) SKIL . For each gene, cumulative results ( n = 5 donors) are showed, together with donors clustered by response to miRNA inhibitor treatment: responders (#162, #217, #255) and non-responders (#152, #157). * p < 0.05

Journal: Stem Cell Research & Therapy

Article Title: Donor-dependent regulation of type II and X collagen deposition by early modulation of miR-335-5p and miR-1246 during chondrogenic commitment

doi: 10.1186/s13287-025-04589-8

Figure Lengend Snippet: qPCR validation of differentially expressed genes. ( A ) GDF5 . ( B ) CCN5 . ( C ) SKIL . For each gene, cumulative results ( n = 5 donors) are showed, together with donors clustered by response to miRNA inhibitor treatment: responders (#162, #217, #255) and non-responders (#152, #157). * p < 0.05

Article Snippet: CNN5 , Hs01031984_m1 , , .

Techniques: Biomarker Discovery

The expression level and diagnostic efficacy of candidate markers (EFNA1, TYMS and WISP2) in CC and OC. A , C The expression level of 3 candidate biomarkers between tumor and normal groups. B , D The ROC curves of the 3 candidate biomarkers in CC and OC

Journal: Discover Oncology

Article Title: Exploration of the shared pathways and common biomarkers in cervical and ovarian cancer using integrated bioinformatics analysis

doi: 10.1007/s12672-024-01725-3

Figure Lengend Snippet: The expression level and diagnostic efficacy of candidate markers (EFNA1, TYMS and WISP2) in CC and OC. A , C The expression level of 3 candidate biomarkers between tumor and normal groups. B , D The ROC curves of the 3 candidate biomarkers in CC and OC

Article Snippet: B , D The ROC curves of the 3 candidate biomarkers in the CC and OC Fig. 7 Protein levels of EFNA1、TYMS and WISP2 in the normal and the tumor tissues in the Human Protein Atlas database (HPA).

Techniques: Expressing, Diagnostic Assay

Expression and diagnostic validation of candidate biomarkers (EFNA1, TYMS and WISP2) in CC and OC. A , C Expression comparison of 3 candidate biomarkers between tumor and normal groups. B , D The ROC curves of the 3 candidate biomarkers in the CC and OC

Journal: Discover Oncology

Article Title: Exploration of the shared pathways and common biomarkers in cervical and ovarian cancer using integrated bioinformatics analysis

doi: 10.1007/s12672-024-01725-3

Figure Lengend Snippet: Expression and diagnostic validation of candidate biomarkers (EFNA1, TYMS and WISP2) in CC and OC. A , C Expression comparison of 3 candidate biomarkers between tumor and normal groups. B , D The ROC curves of the 3 candidate biomarkers in the CC and OC

Article Snippet: B , D The ROC curves of the 3 candidate biomarkers in the CC and OC Fig. 7 Protein levels of EFNA1、TYMS and WISP2 in the normal and the tumor tissues in the Human Protein Atlas database (HPA).

Techniques: Expressing, Diagnostic Assay, Biomarker Discovery, Comparison

Protein levels of EFNA1、TYMS and WISP2 in the normal and the tumor tissues in the Human Protein Atlas database (HPA). Protein levels of EFNA1、TYMS and WISP2 in A , E , I cervical normal tissue, and B , F , J CC tissue. Protein levels of EFNA1、TYMS and WISP2 in C , G , K ovary normal tissue, and D , H , L OC tissue

Journal: Discover Oncology

Article Title: Exploration of the shared pathways and common biomarkers in cervical and ovarian cancer using integrated bioinformatics analysis

doi: 10.1007/s12672-024-01725-3

Figure Lengend Snippet: Protein levels of EFNA1、TYMS and WISP2 in the normal and the tumor tissues in the Human Protein Atlas database (HPA). Protein levels of EFNA1、TYMS and WISP2 in A , E , I cervical normal tissue, and B , F , J CC tissue. Protein levels of EFNA1、TYMS and WISP2 in C , G , K ovary normal tissue, and D , H , L OC tissue

Article Snippet: B , D The ROC curves of the 3 candidate biomarkers in the CC and OC Fig. 7 Protein levels of EFNA1、TYMS and WISP2 in the normal and the tumor tissues in the Human Protein Atlas database (HPA).

Techniques: